Related Experiment Video
Updated: Nov 4, 2025

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
Published on: July 14, 2023
Exploration and Ethical Analysis of Open-label Pediatric Vaccine Trials in a Pandemic
Ian D Wolfe1, Angira Patel2, Larry K Kociolek2
1Children's Minnesota, Minneapolis, Minnesota.
Insights
Vaccinating young children against COVID-19 is crucial. Ethical considerations and parental concerns complicate placebo-controlled vaccine trials, suggesting nonrandomized trials as an alternative for gathering data on pediatric COVID-19 vaccine efficacy.
Area of Science:
- Pediatric infectious diseases
- Clinical trial ethics
- Vaccinology
Background:
- Widespread vaccination is essential to control the spread of coronavirus disease 2019 (COVID-19).
- Initial COVID-19 vaccine trials focused on adult populations, leaving a gap in understanding pediatric vaccine safety and efficacy.
- Ethical and logistical challenges exist in conducting randomized controlled trials (RCTs) for pediatric vaccines during a pandemic.
Purpose of the Study:
- To examine the ethical considerations and feasibility of conducting placebo-controlled vaccine trials in young children.
- To explore alternative trial designs, such as open-label, nonrandomized studies, for evaluating pediatric COVID-19 vaccines.
- To address parental concerns regarding vaccine hesitancy and trial participation in pediatric populations.
Main Methods:
- Discussion of the ethical principles and practical challenges associated with pediatric COVID-19 vaccine trials.
- Analysis of clinical equipoise in the context of established vaccine efficacy in adults and adolescents.
- Consideration of nonrandomized, open-label trial designs to enroll both willing and hesitant parents.
Main Results:
- The established efficacy of COVID-19 vaccines in adults and adolescents raises questions about the ethical justification for placebo-controlled trials in younger children.
- Parental reluctance to enroll children in trials, due to a desire for immediate vaccination or general vaccine hesitancy, presents a significant recruitment barrier.
- Nonrandomized, open-label trials offer a potential strategy to gather essential tolerability and efficacy data in pediatric populations.
Conclusions:
- The ethical landscape for pediatric COVID-19 vaccine trials is complex, necessitating careful consideration of clinical equipoise and parental concerns.
- Alternative trial designs, like open-label studies, may be necessary to obtain crucial data on vaccine performance in children.
- Such approaches can provide valuable guidance for future pediatric vaccine development during public health emergencies.
Abstract:
Young children will ultimately need to be vaccinated to stop the spread of coronavirus disease 2019 (COVID-19). Initial studies of vaccine were performed in adults. Randomized controlled trials are the gold standard. In the COVID-19 pandemic, many questions need to be answered about the ethics and feasibility of these trials. Given the harms of the COVID-19 pandemic and the now-known efficacy of the vaccines in adults and teens, the question of whether clinical equipoise exists for a placebo-controlled trial of vaccines in younger children remains. Parents may be reluctant to enroll children in these trials because they want their child to receive the vaccine or because they are worried about vaccines or clinical trials in general. One option for gathering data on tolerability and efficacy in children would be to use a nonrandomized trial to enroll parents willing to vaccinate their children and those who are hesitant. We discuss the advantages and disadvantages of such an open-label trial that could provide guidance for future pandemics. (Clin Ther.
Related Concept Videos
Vaccinations
Pharmacokinetics in Pediatric Patients: Drug Excretion
Clinical Trials
There are four phases in a clinical trial. A phase one...
Ethics in Research
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

